Trials
Search / Trial NCT06442228

History of Polycystic Ovary Syndrome in First-degree Relatives

Launched by ETLIK ZUBEYDE HANIM WOMEN'S HEALTH CARE, TRAINING AND RESEARCH HOSPITAL · Jun 2, 2024

Trial Information

Current as of February 19, 2025

Completed

Keywords

Male Polycystic Ovary Syndrome Infertility

ClinConnect Summary

This clinical trial is studying the semen analysis of men who have close family members, like a mother or sister, diagnosed with Polycystic Ovary Syndrome (PCOS). The researchers want to understand if there are any differences in the semen of these men compared to those without a family history of PCOS. This is important because PCOS can affect fertility, and knowing more about the male partners’ health can help couples facing infertility challenges.

To participate in this study, men aged 18 to 40 who are in a relationship where they are trying to conceive may be eligible. They should be healthy with no major medical conditions, and they need to agree to provide a semen sample for testing. Participants will simply provide a sample at the hospital and answer some questions about their health. It’s crucial for potential participants to know that men with certain health issues or those who have had specific medical treatments may not qualify for the study. This research aims to improve our understanding of how family history of PCOS could impact male fertility.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • The study will include male partners between the ages of 18-40 who have no known disease, who give spermiogram test for the evaluation of infertile couple in our hospital and who have accepted the consent form verbally and in writing.
  • Exclusion Criteria:
  • Exclusion criteria;
  • 1. History of any chronic disease, urinary tract or reproductive disease, neurological or psychiatric condition in the male patient and recent fever (≥38°C in the last 3 months)
  • 2. Those with a history of vasectomy, cryptorchism, radiation history, chemotherapy, infections, sexual dysfunction and endocrine hypogonadism
  • 3. Especially those with a history of finasteride and dutasteride drug use.

Trial Officials

Yaprak Ustun

Study Director

Ankara Etlik Zubeyde Hanım Women's Health Training and Research Hospital, Ankara, Turkey.

About Etlik Zubeyde Hanım Women's Health Care, Training And Research Hospital

Etlik Zubeyde Hanım Women's Health Care, Training and Research Hospital is a leading healthcare institution dedicated to advancing women's health through comprehensive clinical care, innovative research, and specialized training programs. With a focus on evidence-based practices, the hospital aims to enhance the quality of care for women across various health concerns, including reproductive health, maternal care, and gynecological conditions. The institution is committed to fostering collaboration among healthcare professionals and researchers to improve patient outcomes and contribute to the broader medical community through impactful clinical trials and educational initiatives.

Locations

Ankara, , Turkey

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0